PA
ENSG icon

PharVision Advisers’s The Ensign Group ENSG Stock Holding History

PharVision Advisers’s Portfolio ENSG Stock Details ENSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,148
Closed -$407K – 316
2025
Q1 		$407K Sell
3,148
-540
-15% -$71.5K 0.57% 31
2024
Q4 		$490K Buy
+3,688
New +$536K 0.41% 44

Other funds holding ENSG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's ENSG Position: Q2 2025 in Review

PharVision Advisers sold out of The Ensign Group (ENSG) in Q2 2025, closing a stake of 3,148 shares — an estimated $407K sold.

PharVision Advisers first reported a position in ENSG in Q4 2024 and held it in 2 quarters. The position peaked at $490K in Q4 2024. 491 funds tracked by Wall St. Rank hold ENSG as of Q2 2025.

  • PharVision Advisers reported no remaining The Ensign Group position as of Q2 2025 after selling out during the quarter.
  • PharVision Advisers sold 3,148 The Ensign Group shares in Q2 2025, an estimated $407K.
  • PharVision Advisers first reported a position in The Ensign Group in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's The Ensign Group position peaked at $490K in Q4 2024.
  • 491 funds tracked by Wall St. Rank held The Ensign Group as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.